Clinical Trials
8 trialsNCT06974786 2026-06-04
FASTER
SCRI Development Innovations, LLC
Phase 2 Recruiting
NCT04915248 2026-06-02
FIL_DALYA
Fondazione Italiana Linfomi - ETS
Phase 2 Recruiting
NCT05231629 2026-06-02
MASTER-2
University of Alabama at Birmingham
Phase 2 Recruiting
NCT05434689 2026-06-01
COMMANDER
University of Alabama at Birmingham
Phase 1/2 Active not recruiting
NCT03290950 2026-05-29
A Study of Daratumumab in Patients With Newly Diagnosed Multiple Myeloma
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT06287944 2026-05-18
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
City of Hope Medical Center
Phase 1 Recruiting
NCT06015724 2026-05-15
DARANIVOVAX
Georgetown University
Phase 2 Recruiting
NCT07082270 2026-05-15
Selvigaltin With Standard of Care Treatment for the Treatment of Relapsed/Refractory Multiple Myeloma
Roswell Park Cancer Institute
Phase 1 Withdrawn